Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Study Identifier
P14-506
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).
Study Locations
Location
Status
Location
University of Calgary /ID# 151948
Calgary, Alberta, Canada, T2N 4Z6
Status
Not applicable
Location
Zeidler Ledcor Centre /ID# 135979
Edmonton, Alberta, Canada, T6G 2X8
Status
Not applicable
Location
St. Boniface Clinic, CA /ID# 162092
Winnipeg, Manitoba, Canada, R2H 2A5
Status
Not applicable
Location
Hamilton Health Sciences /ID# 148808
Hamilton, Ontario, Canada, L8L 2X2
Status
Not applicable
Location
Kingston General Hospital /ID# 144942
Kingston, Ontario, Canada, K7L 2V7
Status
Not applicable
Location
London Health Sciences Centre /ID# 138434
London, Ontario, Canada, N6A 5A5
Status
Not applicable
Showing {first} - {last} of {total} Results